Investor's Calendar

September 2023

Mon Tue Wed Thu Fri Sat Sun
28
29
30
31
1
2
3
 
 
 
 
 
 
 
4
5
6
7
8
9
10
 
 
 
 
 
 
 
11
12
13
14
15
16
17
 
 
 
 
 
 
 
18
19
20
21
22
23
24
 
 
 
 
 
 
 
25
26
27
28
29
30
1
 
 
 
 
 
 
 

Next Events

Last News

ROVI takes first place in the Sustainalytics world ESG risk ranking for the second year...
For the second year running, ROVI has obtained the best ranking in the pharmaceutical industry category in...
3 min
04 Aug, 2023
ROVI informs on the evaluation process to obtain marketing authorisation for Risvan®
Risperidone ISM® is a prolonged-release injectable antipsychotic developed and patented by ROVI for the...
1 min
28 Jul, 2023
First half 2023 results press release
ROVI achieved stable total revenue of 381.0 million euros in the first post-pandemic half year
4 min
26 Jul, 2023

See more

Financial and Business Information

Information for investors

Marta Campos

Marta Campos

Head of Investor Relations

mcampos@rovi.es

Antonio Marquina

Antonio Marquina

Investor Relations

amarquina@rovi.es

buzón general Rovi

General Email

ir@rovi.es